Skip to content

Study · In vitro (cells) · sheep · 2002

9 results

The effect of two-day treatment of primary cultured ovine somatotropes with GHRP-2 on membrane voltage-gated K+ currents.

Chen C

Endocrinology1 Jul 2002Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study9

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In cultured ovine somatotropes, 48-h GHRP‑2 treatment increased the percentage of cells with spontaneous action potentials, 51% versus 27%.

    In plain wordsIn cultured sheep pituitary cells, two days of GHRP‑2 raised the share of cells that fire spontaneously.

    Peptide
    GHRP-2
    Outcome
    IncreaseCells with spontaneous action potential
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    Untreated cells
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    10(-8) M · 48 hAs given in this study (sheep).

    Measurements

    Cells with spontaneous action potential
    51%
    GHRP-2 48 h
    Cells with spontaneous action potential
    27%
    control

    Source sentences

    Summary
    After 48-h treatment with GHRP-2 (10(-8) M), the percentage of cells with spontaneous action potential was increased (51 vs. 27%) without change of resting potential.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.
  2. 02LabIn vitro (cells)Mechanism

    In cultured ovine somatotropes, 48-h GHRP‑2 treatment did not change the resting potential.

    In plain wordsIn cultured sheep pituitary cells, two days of GHRP‑2 did not change the resting voltage.

    Peptide
    GHRP-2
    Outcome
    No significant changeResting potential
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    Untreated cells
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    10(-8) M · 48 hAs given in this study (sheep).

    Source sentences

    Summary
    without change of resting potential.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.
  3. 03LabIn vitro (cells)Mechanism

    In cultured ovine somatotropes, 48-h GHRP‑2 treatment increased the amplitude of voltage-gated K+ currents, mainly the transient A-type-like current.

    In plain wordsIn cultured sheep pituitary cells, two days of GHRP‑2 increased potassium currents.

    Peptide
    GHRP-2
    Outcome
    IncreaseAmplitude of voltage-gated K+ currents
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    Untreated cells
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    10(-8) M · 48 hAs given in this study (sheep).

    Source sentences

    Summary
    This GHRP-2 treatment also increased the amplitude of voltage-gated K+ currents (predominantly transient A-type-like current but also delayed rectifier or K-type-like current) without modification of biophysical kinetics.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.
  4. 04LabIn vitro (cells)Mechanism

    In cultured ovine somatotropes, 48-h GHRP‑2 treatment did not modify the biophysical kinetics of K+ currents.

    In plain wordsIn cultured sheep pituitary cells, two days of GHRP‑2 did not change how the potassium currents behave over time.

    Peptide
    GHRP-2
    Outcome
    No significant changeBiophysical kinetics of K+ currents
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    Untreated cells
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    10(-8) M · 48 hAs given in this study (sheep).

    Source sentences

    Summary
    without modification of biophysical kinetics.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

Studies that did not test the peptide alone5

In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-2.

  1. 05LabNot a test of GHRP-2 aloneIn vitro (cells)Mechanism

    In cultured ovine somatotropes, down-regulation of PKC with phorbol 12-myristate 13-acetate blocked the GHRP‑2-induced increase in K+ currents.

    In plain wordsIn cultured sheep pituitary cells, switching off PKC blocked the potassium current increase caused by GHRP‑2.

    Peptide
    GHRP-2
    Outcome
    DecreaseGHRP-2-induced K+ current increase after PKC down-regulation
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    GHRP-2 without PMA
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Down-regulation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate at the time of adding GHRP-2 blocked the increase in K+ currents.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

  2. 06LabNot a test of GHRP-2 aloneIn vitro (cells)Mechanism

    In cultured ovine somatotropes, the PKC inhibitor calphostin C significantly reduced the GHRP‑2-induced increase in K+ currents.

    In plain wordsIn cultured sheep pituitary cells, a PKC blocker reduced the potassium current increase caused by GHRP‑2.

    Peptide
    GHRP-2
    Outcome
    DecreaseGHRP-2-induced K+ current increase with calphostin C
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    GHRP-2 without inhibitor
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Inclusion of calphostin C (PKC inhibitor) but not H(89) (protein kinase A inhibitor) significantly reduced the increase in K+ currents by GHRP-2.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

  3. 07LabNot a test of GHRP-2 aloneIn vitro (cells)Mechanism

    In cultured ovine somatotropes, the protein kinase A inhibitor H89 did not significantly reduce the GHRP‑2-induced increase in K+ currents.

    In plain wordsIn cultured sheep pituitary cells, a protein kinase A blocker did not reduce the potassium current increase caused by GHRP‑2.

    Peptide
    GHRP-2
    Outcome
    No significant changeGHRP-2-induced K+ current increase with H89
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    GHRP-2 without inhibitor
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Inclusion of calphostin C (PKC inhibitor) but not H(89) (protein kinase A inhibitor) significantly reduced the increase in K+ currents by GHRP-2.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

  4. 08LabNot a test of GHRP-2 aloneIn vitro (cells)Mechanism

    In cultured ovine somatotropes, the transcription inhibitor actinomycin D abolished the GHRP‑2-induced increase in K+ currents.

    In plain wordsIn cultured sheep pituitary cells, blocking gene transcription stopped the potassium current increase caused by GHRP‑2.

    Peptide
    GHRP-2
    Outcome
    DecreaseGHRP-2-induced K+ current increase with actinomycin D
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    GHRP-2 without inhibitor
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Inclusion of actinomycin D (transcription inhibitor) or cycloheximide (protein synthesis inhibitor) abolished the increase in K+ currents.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

  5. 09LabNot a test of GHRP-2 aloneIn vitro (cells)Mechanism

    In cultured ovine somatotropes, the protein synthesis inhibitor cycloheximide abolished the GHRP‑2-induced increase in K+ currents.

    In plain wordsIn cultured sheep pituitary cells, blocking protein synthesis stopped the potassium current increase caused by GHRP‑2.

    Peptide
    GHRP-2
    Outcome
    DecreaseGHRP-2-induced K+ current increase with cycloheximide
    Study

    sheepn: not reported in source

    Primary cultured ovine somatotropes, whole-cell patch clamp
    Comparator
    GHRP-2 without inhibitor
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Inclusion of actinomycin D (transcription inhibitor) or cycloheximide (protein synthesis inhibitor) abolished the increase in K+ currents.
    2 context sentences
    Summary · context
    In this experiment, somatotropes were obtained from ovine pituitaries by enzyme dissociation and enriched by density centrifugation.
    Summary · context
    Membrane voltage and currents were recorded with whole-cell patch-clamp configuration.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.